| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1090937545 |
| P356 | DOI | 10.1186/S40478-017-0461-5 |
| P932 | PMC publication ID | 5537936 |
| P698 | PubMed publication ID | 28760161 |
| P50 | author | Keizō Takao | Q59453900 |
| Takami Tomiyama | Q88643233 | ||
| P2093 | author name string | Yuki Fujita | |
| Hiroshi Mori | |||
| Tetsuya Kimura | |||
| Takashi Morita | |||
| Yuki Yamashita | |||
| Tsuyoshi Miyakawa | |||
| Hiroshi Takuma | |||
| Shogo Matsuyama | |||
| Kayo Yoshida | |||
| Tomohiro Umeda | |||
| Akihiko Takashima | |||
| Ayumi Sakai | |||
| Mamiko Suzuki | |||
| Kiyouhisa Ohnishi | |||
| Minato Yamashita | |||
| P2860 | cites work | The E693Delta mutation in amyloid precursor protein increases intracellular accumulation of amyloid beta oligomers and causes endoplasmic reticulum stress-induced apoptosis in cultured cells | Q37150804 |
| A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. | Q37309370 | ||
| Amyloid precursor protein processing and Alzheimer's disease | Q37860317 | ||
| The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes | Q37979641 | ||
| GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease | Q38225536 | ||
| Storm before the quiet: neuronal hyperactivity and Aβ in the presymptomatic stages of Alzheimer's disease | Q38274705 | ||
| Neuronal activity and amyloid plaque pathology: an update | Q38601447 | ||
| Benzodiazepine Use Attenuates Cortical β-Amyloid and is Not Associated with Progressive Cognitive Decline in Nondemented Elderly Adults: A Pilot Study Using F(18)-Florbetapir Positron Emission Tomography | Q38810525 | ||
| Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype | Q41151004 | ||
| Major amyloid-β-degrading enzymes, endothelin-converting enzyme-2 and neprilysin, are expressed by distinct populations of GABAergic interneurons in hippocampus and neocortex | Q46152909 | ||
| Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice | Q48846848 | ||
| Clinical course of patients with familial early-onset Alzheimer's disease potentially lacking senile plaques bearing the E693Δ mutation in amyloid precursor protein | Q48946574 | ||
| Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers. | Q50525085 | ||
| A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo. | Q51059487 | ||
| A second pedigree with amyloid-less familial Alzheimer's disease harboring an identical mutation in the amyloid precursor protein gene (E693delta). | Q53362350 | ||
| A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. | Q53391715 | ||
| A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline | Q22251083 | ||
| Molecular genetics of early-onset Alzheimer's disease revisited | Q26750717 | ||
| GABA(A) receptor-mediated acceleration of aging-associated memory decline in APP/PS1 mice and its pharmacological treatment by picrotoxin | Q27300708 | ||
| Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction | Q29547778 | ||
| APP processing and synaptic function | Q29615873 | ||
| Comprehensive behavioral analysis of cluster of differentiation 47 knockout mice | Q30442674 | ||
| Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice | Q33252237 | ||
| Decreased γ-aminobutyric acid levels in the parietal region of patients with Alzheimer's disease | Q33907438 | ||
| The amyloid precursor protein controls adult hippocampal neurogenesis through GABAergic interneurons | Q34268936 | ||
| Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease | Q34544243 | ||
| A dynamic relationship between intracellular and extracellular pools of Abeta | Q35070713 | ||
| Promotion of liver and lung tumorigenesis in DEN-treated cytoglobin-deficient mice | Q35168131 | ||
| Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis | Q35327172 | ||
| Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology | Q35747757 | ||
| Intraneuronal Abeta42 accumulation in human brain. | Q35793325 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 1 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 59 | |
| P577 | publication date | 2017-07-31 | |
| P1433 | published in | Acta Neuropathologica Communications | Q27724912 |
| P1476 | title | Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer's disease: analysis of Osaka mutation-knockin mice | |
| P478 | volume | 5 |
| Q89861110 | APP Osaka Mutation in Familial Alzheimer's Disease-Its Discovery, Phenotypes, and Mechanism of Recessive Inheritance |
| Q97882884 | GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment |
| Q64100324 | Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration |
| Q64087524 | Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer's Disease |
Search more.